Related Experiment Videos
Fenoterol inhalation powder and aerosol
European Journal of Respiratory Diseases. Supplement
|January 1, 1983
Summary
Comparing fenoterol powder and metered dose inhalers in chronic obstructive lung disease patients showed similar effects on lung function and pulse rate. Patients found the powder inhaler simple to use.
Area of Science:
- Pharmacology
- Respiratory Medicine
- Clinical Trials
Background:
- Fenoterol is a bronchodilator used for chronic obstructive lung disease (COPD).
- Different delivery methods, such as inhalation powder and metered dose inhalers (MDIs), may affect drug efficacy and patient experience.
- Optimizing drug delivery is crucial for managing COPD symptoms.
Purpose of the Study:
- To compare the efficacy of fenoterol inhalation powder versus fenoterol from a metered dose inhaler in COPD patients.
- To assess the impact of each delivery method on lung function and pulse rate.
- To evaluate patient preference and ease of use for the different inhaler types.
Main Methods:
- A double-dummy, cross-over study design was employed.
- Ten patients diagnosed with chronic obstructive lung disease participated.
- Lung function and pulse rate were monitored for up to 6 hours post-inhalation.
Main Results:
- No statistically significant differences were observed in lung function between the fenoterol powder and MDI groups.
- Pulse rate changes were comparable between the two delivery methods.
- Patients reported the inhalation powder via the Ingelheim inhaler as simple to use.
Conclusions:
- Fenoterol inhalation powder and metered dose inhalers demonstrate comparable short-term efficacy in COPD patients.
- The choice of delivery device may be influenced by patient-reported ease of use.
- Further research could explore long-term outcomes and patient adherence with different fenoterol delivery systems.